Repression of miR-143 Mediates Cr (VI)–Induced Tumor Angiogenesis via IGF-IR/IRS1/ERK/IL-8 Pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repression of miR-143 Mediates Cr (VI)–Induced Tumor Angiogenesis via IGF-IR/IRS1/ERK/IL-8 Pathway
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 134, Issue 1, Pages 26-38
Publisher
Oxford University Press (OUP)
Online
2013-06-08
DOI
10.1093/toxsci/kft101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thrombin-induced NF-κB activation and IL-8/CXCL8 release is mediated by c-Src-dependent Shc, Raf-1, and ERK pathways in lung epithelial cells
- (2013) Chien-Huang Lin et al. CELLULAR SIGNALLING
- Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India
- (2012) Nandana Das et al. BMC PUBLIC HEALTH
- Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation
- (2012) Jun He et al. EMBO REPORTS
- Multifunctional Role of Bcl-2 in Malignant Transformation and Tumorigenesis of Cr(VI)-Transformed Lung Cells
- (2012) Djordje Medan et al. PLoS One
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Small RNA Sequencing and Functional Characterization Reveals MicroRNA-143 Tumor Suppressor Activity in Liposarcoma
- (2011) S. Ugras et al. CANCER RESEARCH
- The role of insulin receptor substrate-1 in the oncogenicity of simian virus 40 T antigen
- (2011) An Wu et al. CELL CYCLE
- Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies
- (2011) Timothy A Yap et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α
- (2011) Athanasios Karapetsas et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening
- (2011) Sven Wach et al. INTERNATIONAL JOURNAL OF CANCER
- EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet-Promoted Murine Colon Cancer: Role of G1 Regulators
- (2011) H. Zhu et al. MOLECULAR CANCER RESEARCH
- NADPH Oxidase Activation Is Required in Reactive Oxygen Species Generation and Cell Transformation Induced by Hexavalent Chromium
- (2011) Xin Wang et al. TOXICOLOGICAL SCIENCES
- Reversal and Prevention of Arsenic-Induced Human Bronchial Epithelial Cell Malignant Transformation by microRNA-200b
- (2011) Zhishan Wang et al. TOXICOLOGICAL SCIENCES
- Involvement of microRNAs in lung cancer biology and therapy
- (2011) Xi Liu et al. Translational Research
- Role of oxidative/nitrosative stress-mediated Bcl-2 regulation in apoptosis and malignant transformation
- (2010) Neelam Azad et al. Annals of the New York Academy of Sciences
- Exposure to Metal-Rich Particulate Matter Modifies the Expression of Candidate MicroRNAs in Peripheral Blood Leukocytes
- (2010) Valentina Bollati et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
- (2010) O. A. Kent et al. GENES & DEVELOPMENT
- Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure
- (2010) Abdellah H. K. Ali et al. MOLECULAR CARCINOGENESIS
- MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145
- (2010) Bing-Li Wu WORLD JOURNAL OF GASTROENTEROLOGY
- Human bronchial epithelial cells malignantly transformed by hexavalent chromium exhibit an aneuploid phenotype but no microsatellite instability
- (2009) C.F.D. Rodrigues et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Immunohistochemistry in the evaluation of neovascularization in tumor xenografts
- (2008) D Wang et al. BIOTECHNIC & HISTOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started